Brevan Howard Capital Management LP

Q3 2017 13F Holdings Report, Stock Holdings

Signature - Title
Nigel Lawrence - Authorised Signatory
Location
St. Helier, Jersey
Holdings as of
30 Sep 2017
Value $
$43,463,000
Num holdings
30
Filing time
14 Nov 2017, 16:14:25 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included CME, LQD, EMB, CBLAQ, and TWX.
Previous filing
Q2 2017 - 14 Aug 2017
Next filing
Q4 2020 - 12 Feb 2021
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2017 Q3 compared to 2017 Q2 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nigel Lawrence Authorised Signatory St. Helier, Jersey 14 Nov 2017

*NOTE: THE INVESTMENT MANAGER FILING THIS REPORT IS DEEMED TO HAVE INVESTMENT DISCRETION WITH RESPECT TO SECURITIES OVER WHICH BREVAN HOWARD (HONG KONG) LIMITED ("BHHK"), BREVAN HOWARD INVESTMENT PRODUCTS LIMITED ("BHIPL"), BREVAN HOWARD ASSET MANAGEMENT LLP ("BHAM"), BREVAN HOWARD US INVESTMENT MANAGEMENT LP ("BHUS"), BREVAN HOWARD (ISRAEL) LTD. ("BH ISRAEL"), AND BREVAN HOWARD PRIVATE LIMITED ("BHPL") SUBSIDIARIES OF THE INVESTMENT MANAGER, EXERCISE INVESTMENT DISCRETION AS A RESULT OF THE INVESTMENT MANAGER HAVING CONTROL OVER BHHK, BHIPL, BHAM, BHUS, BH ISRAEL, AND BHPL.